In accordance with ex vivo data, each of the selective ETAR antagonists [26, 28], the nonselective ETAR/ETBR antagonist [25, 27, 28] and the ECE inhibitor [29] have been reported to suppress increases in NE levels resulting from myocardial ischemia. This evidence concerns the gene EDNRB and myocardial ischemia.